Glaucoma News

Teprotumumab for Thyroid Eye Disease: What You Need to Know Now Thyroid Eye Disease (TED), also known as Graves’ ophthalmopathy, has long been one of the most difficult autoimmune eye conditions to treat. For years, management options were limited to steroids, radiation therapy, or surgery to control symptoms such as eye bulging, double vision, and […]

A Triathlete’s Wavy Vision Revealed a Devastating Diagnosis For a triathlete, the body is a finely tuned machine. Every heartbeat, every muscle fiber, every breath is calibrated for peak performance. So, when something feels off, it’s a signal that cannot be ignored. This was the reality for one dedicated athlete, whose journey from a subtle

AI Eye Scans Reveal Retinal Age and Predict Disease Risk For centuries, the eyes have been called the windows to the soul. Now, thanks to groundbreaking artificial intelligence, they are becoming a clear window into our overall health and biological age. A revolutionary new study has demonstrated that a simple, non-invasive eye scan, analyzed by

Midlife Eye Problems for Women Are Now More Treatable Than Ever For many women, midlife is a period of profound change and empowerment. Yet, alongside this new chapter often comes a set of unexpected physical shifts, and our eyes are no exception. Blurred vision, dryness, difficulty seeing at night, or the sudden need for reading

The Hidden Dangers of Buying Prescription Eye Drops Online In our fast-paced, digital world, the convenience of online shopping extends to almost everything—including our health. A quick search can yield dozens of websites promising to deliver prescription medications, from antibiotics to potent eye drops, right to your doorstep without the hassle of a doctor’s visit.

MeiraGTx Reacquires Eye Gene Therapy from J&J After Clinical Setback In the high-stakes world of gene therapy, the path to a breakthrough is rarely a straight line. A recent and significant development underscores this reality, as biotech company MeiraGTx has taken back full control of a promising eye disease treatment from pharmaceutical giant Johnson &

MeiraGTx Reclaims Genetic Eye Disease Drug Rights From Johnson & Johnson In a significant shift within the gene therapy landscape, MeiraGTx Holdings plc has announced the full reacquisition of the rights to its investigational genetic eye disease programs from Johnson & Johnson. This move, detailed in a recent SEC filing, marks a pivotal moment for

Ocugen Aims for Three Gene Therapy Approvals to Democratize Treatment For decades, gene therapy has shimmered on the horizon of medicine—a revolutionary promise to cure, not just manage, inherited diseases. Yet, for many, it has remained a distant, often prohibitively expensive, beacon. One biotech company, Ocugen, is on a mission to change that narrative. With

PYC Therapeutics Advances Blinding Eye Disease Drug Trials: A New Dawn for Patients For the hundreds of thousands of individuals worldwide living with inherited retinal diseases (IRDs), the world can slowly fade to darkness. These genetic conditions, which include retinitis pigmentosa and Stargardt disease, have long been considered untreatable, leading to progressive vision loss and,

Protect Your Vision: 5 Daily Habits That Harm Your Eye Health We often think of our eyes as windows to the world, but do we treat them with the care they deserve? In our fast-paced, screen-dominated lives, it’s easy to take our vision for granted, assuming it will simply endure whatever we throw at it.